A Pilot Study to Evaluate Impairment of Sexual Function with Vulvar Dermatosis – An Indian Experience

Introduction: Vulval skin disorders significantly impact individuals, affecting physical well-being, mental state, and sexual health. There is limited research on vulvar dermatoses (VD) affecting the sexual function, especially in the Indian population. Materials and Methods: This pilot study, spanning from September 2021 to April 2023, includes female patients within the age group of 18–65 years who were sexually active with genital dermatoses. Patients with chronic systemic illness and sexual transmitted disease were excluded. A questionnaire comprising of 7 questions were formed including domains such as difficulties in sexual activity, satisfaction, worry, embarrassment, pain, partner issue, and change in frequency of sexual intercourse. The questionnaire was validated by four subject experts. The details were recorded in a prestructured pro forma. Independent t -test and ANOVA were used to find the statistical association. Results: In the study involving 86 females with vulvar conditions, 17 exhibited an impact on the sexual function impairment (SFI) scale, with 82.35% reporting a small effect and 17.64% a moderate effect. None reported a large effect. The average SFI score among patients having disease duration of 1–3 months, 3–6 months, and >6 months was 3.83 ± 2.14, 7.67 ± 3.78, and 4.87 ± 5.54, respectively. Maximum average SFI score associated with warts and lichen planus was 12 followed by 5.5 ± 2.12 in candidiasis, 5 ± 4.76 in tinea cruris/corporis, and 5 in cutaneous metastasis. Discussion and Conclusion: A small, superficial, asymptomatic lesion over genitals may cause significant impact on the nature of sexual activity. Compared to previous questionnaires, it is simpler questionnaire, easy to understand, and less time-consuming for both the patient and physician. Limitations: Small sample size.